With a new clinical practice guideline, primary care providers can offer the best stroke rehabilitation care possible to ...

CLARKSBURG, MARYLAND / ACCESS Newswire / February 21, 2025 / Nine months after the U.S. Food and Drug Administration (FDA) approved self-collected Human Papillomavirus (HPV) testing as an alternative ...

Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in competitive sports after shared decision-making with their clinicians about ...

A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom.

Study results show most patients prefer more frequent colonoscopies, but specialist recommendations drive acceptance of extended intervals.

Protect your brain health by reducing dementia risk. Small amounts of physical activity can lead to big benefits for older ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI ™ for all indications matching the reference product Stelara ® (ustekinumab) and has granted a provisional determination ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Identifying food allergies in children can be challenging, as symptoms may vary and can be mistaken for other conditions. However, being aware of the common allergens and recogniz ...

Panelists discuss exciting updates on Bruton tyrosine kinase (BTK) inhibitors from the 2024 American Society of Hematology ...

Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...

To tackle the ongoing high burden of hepatitis C virus (HCV) infections among people who inject drugs (PWID), WHO has set a specific incidence target among PWID of no more than two new infections per ...